Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.

Source:http://linkedlifedata.com/resource/pubmed/id/19339808

Download in:

View as

General Info

PMID
19339808